AI-powered MRIs could cut the potentially toxic dyes used in traditional MRIs by up to 80 percent, but will patients embrace AI-driven brain scans?
COMPASS Pathways’ key patents upheld by the US Patent and Trademark Office | Psychedelic Invest
COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation, announced today that the US Patent Trial